Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period
Latest Information Update: 16 Oct 2024
At a glance
- Drugs Pitolisant (Primary)
- Indications Cataplexy; Narcolepsy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Bioprojet
Most Recent Events
- 16 Oct 2024 Last checked against ClincalTrials.gov record.
- 03 Oct 2024 Planned End Date changed from 1 Oct 2024 to 1 Mar 2025.
- 19 Sep 2024 Planned End Date changed from 1 Dec 2023 to 1 Oct 2024.